Inferior Vena Cava Filter for Prevention of Pulmonary Embolism in Recurrent Venous Thrombosis; Initial Experience in Assuit University Hospitals
/ 0
- Details
- Category: Vol. 81, March 2013
- Hits: 546
Inferior Vena Cava Filter for Prevention of Pulmonary Embolism in Recurrent Venous Thrombosis; Initial Experience in Assuit University Hospitals,MOUSTAFA H.M. OTHMAN, KHALED A. ATTALLA, MOHAMED Z. MOHAMED and EMAN ABO ELHAMD
Abstract
Objectives: To assess the role of IVC filter in prophylaxis of pulmonary embolism in recurrent deep venous thrombosis and to gain our first experience in placement of IVC filters.
Patients and Methods: Thirty patients (10 male and 20 female) with recurrent deep venous thrombosis which carried high risk of pulmonary embolism, their ages ranging from 22-58 years old were included in this study that was done in Assuit University Hospital from January, 2010 to January, 2012. All thirty patients were subjected to anticoagulation (unfractionated heparin along with warfarin). Half of them receiving IVC filter & the other one have not. We use the Trap Ease Filter (Cordis Endovascular, Johnson and Johnson, Warren, NJ) which was approved for use in the United States in 2000 and it is MRI compatible and creates minimal artifact on MR images. Follow-up of both groups at 12 days and one years for occurrence of pulmonary embolism.
Results: At 12 day follow-up 2 deaths and 3 patients developed pulmonary embolism in non filter group patients while neither deaths nor pulmonary embolism were recorded in filter group patients at the same period. At one year follow-up, 5 deaths and 4 patients develop pulmonary embolism in non-filter group, also 4 deaths and 2 patients develop pulmo-nary embolism from the filter group at that same period. 5 patients who had a filter develop recurrent DVT at one year follow-up while only 3 patients who take only anticoagulant developed recurrent DVT. 5 patients from filter and non filter groups developed bleeding in 12-day follow-up while in one year follow-up 6 patients from non filter group developed bleeding and 7 patients from filter group develop bleeding.
Conclusion: Studying of the results justify the use of IVC filter along with anticoagulants in patient with risk of pulmo-nary embolism.